PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of eidLink to Publisher's site
 
Emerg Infect Dis. 2000 Nov-Dec; 6(6): 601–608.
PMCID: PMC2640913
Hemophagocytic syndromes and infection.
D. N. Fisman
Beth Israel Deaconess Medical Center, Boston, Massachusetts 02215, USA.
D. N. Fisman: dfisman/at/hsph.harvard.edu
Abstract
Hemophagocytic lymphohistiocytosis (HLH) is an unusual syndrome characterized by fever, splenomegaly, jaundice, and the pathologic finding of hemophagocytosis (phagocytosis by macrophages of erythrocytes, leukocytes, platelets, and their precursors) in bone marrow and other tissues. HLH may be diagnosed in association with malignant, genetic, or autoimmune diseases but is also prominently linked with Epstein-Barr (EBV) virus infection. Hyperproduction of cytokines, including interferon-gamma and tumor necrosis factor-alpha, by EBV- infected T lymphocytes may play a role in the pathogenesis of HLH. EBV-associated HLH may mimic T-cell lymphoma and is treated with cytotoxic chemotherapy, while hemophagocytic syndromes associated with nonviral pathogens often respond to treatment of the underlying infection.
Full Text
The Full Text of this article is available as a PDF (59K).
Articles from Emerging Infectious Diseases are provided here courtesy of
Centers for Disease Control and Prevention